Eric Joseph Daniels - 01 Apr 2026 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Key filing fact

Eric Joseph Daniels filed Form 4 for KIORA PHARMACEUTICALS INC (KPRX) on 02 Apr 2026.

Key facts

This page summarizes Eric Joseph Daniels's Form 4 filing for KIORA PHARMACEUTICALS INC (KPRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Apr 2026, 16:46.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001892943 Primary reporting owner

Relationship: Chief Development Officer
Address: C/O KIORA PHARMACEUTICALS, INC., 169 SAXONY RD., SUITE 212, ENCINITAS
Signature: /s/ Melissa Tosca, Attorney-in-Fact
Signature date: 02 Apr 2026

Shares, units, or other non-derivative securities reported in this filing.

KPRX transaction

Tax liability

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

SEC remarks

Net share settlement, shares withheld for employee tax obligation upon vesting of restricted stock.